Auriga Research Private Limited is a Clinical Research Organization (CRO) founded in 1990 in India, specializing in Pharmacovigilance, Clinical Trials Services, and Analytical Testing, Inspection, and Certification in the Pharmaceutical industry. The company offers a comprehensive range of services, including the maintenance of Pharmacovigilance Safety database for drugs, vaccines, and devices, as well as management of safety system master files, ICSR case processing and reporting, literature review, periodic aggregate report writing, signal detection and management, and various other pharmacovigilance activities. Additionally, Auriga provides end-to-end clinical trials services such as medical writing, regulatory submission, site management, monitoring, and statistical analysis utilizing state-of-the-art tools including Clinical Trial Management System (CTMS), Master Data Management (MDM), electronic Trial Master Files (eTMF), and others. The company also offers Bioequivalence Monitoring, Pharmacokinetic Analysis, and Cosmetic product safety & efficacy studies. Auriga's capabilities are further enhanced by its cloud-based easy-to-use Pharmacovigilance Safety System (PV Database), along with AI, Analytics, and Safety signals capabilities, which provide a comprehensive and regulatory compliant solution for pharmacovigilance and drug safety activities. With its broad service offering and robust technological infrastructure, Auriga Research Private Limited stands as a significant player in the pharmaceutical research and development sector, catering to the growing needs of the industry.
There is no investment information
No recent news or press coverage available for Auriga Research Private Limited.